title: Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial.
abstract: The human immune response to monoclonal antibody-enzyme conjugates has been studied in patients included in the pilot clinical trial of ADEPT. Each patient received murine monoclonal anti-CEA antibody fragments (A5B7-F(ab')2, conjugated to bacterial enzyme, carboxypeptidase G2 (CPG2) followed by a galactosylated monoclonal anti-CPG2 antibody (SB43), 36-48 h after the conjugate. Some patients were also given a dose of 131I-labeled conjugate (4-8 mg, 7-15 mCi) for blood clearance and gamma camera image studies. All patients studied developed human antimouse antibodies (HAMA) and anti-CPG2 antibodies within 10 d after a single course of treatment with the conjugate. In most cases, IgM response was detected at 7 d after the conjugate followed by the IgG response 14 d later. In one patient, HAMA and anti-CPG2 antibodies of the IgG type could still be detected at 10 mo after treatment. Anti-CPG2 antibodies in serum of one patient were found to inhibit CPG2 activity in vitro. Generation of neutralizing antibodies limits the use of repeat cycles of ADEPT in patients. Use of immunosuppressive agents may allow a useful time window for several ADEPT cycle treatments by delaying the appearance of HAMA and anti-CPG2 antibodies. Patients given cyclosporin A before and during ADEPT are currently being studied for HAMA and anti-CPG2 response.
authors.affiliation: Department of Medical Oncology, Charing Cross Hospital, London, UK.
authors.forename: S K
authors.initials: SK
authors.lastname: Sharma
authors.forename: K D
authors.initials: KD
authors.lastname: Bagshawe
authors.forename: R G
authors.initials: RG
authors.lastname: Melton
authors.forename: R F
authors.initials: RF
authors.lastname: Sherwood
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000378:metabolism; D000917:Antibody Formation / Q000276:immunology*; D002268:Carboxypeptidases / Q000276:immunology / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D015902:Gamma Cameras; D006801:Humans; D007167:Immunotherapy; D007457:Iodine Radioisotopes; D051379:Mice; D008807:Mice, Inbred BALB C; D010865:Pilot Projects; D011355:Prodrugs / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes; D011355:Prodrugs; D002268:Carboxypeptidases